Healthcare mergers and acquisitions are fraught with unique risks, and cybersecurity is at the top of the list. While the “perfect deal” often looks great on paper, a hidden vulnerability, an undisclosed breach, or a misaligned security program can destroy its value, trigger significant legal penalties, and cause irreparable reputational damage.
I’ve spent much of my career witnessing firsthand the effects of healthcare cybersecurity and compliance issues on M&A scenarios. At the American Health Law Association (AHLA) Long Term and Post-Acute Care Law and Compliance conference (taking place from February 23-25, 2026 in Nashville, TN,) I’ll be discussing this topic along with Christina Hultsch, partner at Benesch Friedlander Coplan & Aronoff LLP, during the session, “From Due Diligence to Data Integration: The Critical Role of Cybersecurity in Healthcare M&A.”
The New Reality of Healthcare M&A
We’ve moved past the era where healthcare cybersecurity is simply a line item for the IT department to “check off” during the final stages of a deal. For example, in today’s regulatory environment, HIPAA law requires covered entities to safeguard against “reasonably anticipated” threats to protected health information. However, complex, ever-changing regulations, increased vulnerabilities, implementation of new technologies, and changes in business processes can make it challenging to stay ahead of emerging threats.
At BlueOrange, our focus has always been on simplifying compliance, security, and privacy in healthcare. We believe that safeguarding protected health information (PHI) is more than a regulatory hurdle; it is also a fundamental requirement of care delivery.
During our discussion, Christina and I will provide a comprehensive roadmap for both buyers and sellers, outlining their respective responsibilities and strategies for managing cybersecurity throughout the M&A lifecycle. This includes:
- Pre-Deal Due Diligence: How to identify “reasonably anticipated” threats before deal close.
- The Crucial Role of Reps & Warranties Insurance: How to use legal tools to mitigate the risks that even the best due diligence may miss.
- Post-Merger Integration Challenges: How to merge two distinct cybersecurity cultures and healthcare IT environments without creating new holes for malicious actors to exploit.
Christina brings an incredible depth of experience in healthcare regulatory matters and cybersecurity risk management, while I’ll be bringing the perspective of someone who has sat in the CIO chair and now helps organizations navigate these exact compliance journeys. Together, we aim to help our audience bridge the gap between legal theory and operational reality.
Join us on Monday, February 23 at 2:45 pm or Wednesday, February 25 at 9:30 am. We hope to see you there.
By John DiMaggio, CEO, BlueOrange Compliance
